capecitabine has been researched along with Leukemia, Myeloid, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joseph, R; Mathews, S; McRee, AJ; Zeidner, JF | 1 |
| Gibbons, S; Tansley, S | 1 |
| Bellavia, T; Damodaran, S; Khushalani, NI; Sait, SN; Wang, ES; Wetzler, M | 1 |
3 other study(ies) available for capecitabine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Inversion 16 (inv(16)) acute myeloid leukemia (AML) following treatment with radiation, capecitabine, and temozolomide in a patient with metastatic neuroendocrine tumor (NET).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Chromosome Inversion; Chromosomes, Human, Pair 16; Female; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Neuroendocrine Tumors; Palliative Care; Prognosis; Temozolomide | 2019 |
Capecitabine-induced acute myeloid leukaemia.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Leukemia, Myeloid, Acute; Male; Prodrugs; Sigmoid Neoplasms | 2009 |
Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer.
Topics: Abnormal Karyotype; Adenocarcinoma; Antineoplastic Agents; Capecitabine; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Deoxycytidine; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Organoplatinum Compounds; Oxaliplatin; Radiotherapy; Translocation, Genetic | 2012 |